Next-Gen Shrimp Immunity: Revolutionary Aquaculture Tech

The original patent, 'Method for improving immunity in shrimps', demonstrated the effectiveness of cocoa rind extracts in enhancing immunity. However, the method had limitations, such as the need for manual administration and the lack of targeted disease resistance. The present invention addresses these limitations by introducing paradigm-shifting approaches to immunity enhancement, including vaccine-based, feed-based, bioreactor-based, personalized, and nano-formulation-based solutions.

The new claims introduce multiple novel elements, including the use of micro-encapsulation, engineered antimicrobial peptides, bioreactor design, genotyping-based personalization, and nano-formulation. These innovations overcome the limitations of the original patent, providing a non-obvious and significant advancement in the field.

Other potential implementations of the invention could include alternative delivery mechanisms, such as implantable devices or aerosol administration, as well as the integration of machine learning algorithms to optimize treatment regimens. Additionally, the use of different types of extracts or bioactive compounds could be explored to further expand the invention's scope.

The next-generation immunity enhancement systems disclosed herein have significant commercial potential in the aquaculture industry, with potential applications in disease prevention, reduced antibiotic use, and improved animal welfare. The market for these innovations is substantial, with the global aquaculture market projected to reach USD 245 billion by 2027.